Biomolecules-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2025-03-03 ms6000002098058965 来自湖北省

偏重的研究方向：肿瘤
经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2025-01-15 ms8000001635701835 来自山西省

刚投

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2024-12-25 Jin0412 来自福建省

pend review 记录一下

11 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2022-06-19 zphgccf

审稿速度:1.0
经验分享：从投稿到接受19天，非常快。

135 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2024-07-17 ms8000001798355465 来自重庆

要版面费吗

89 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2021-04-09 1891e859aem

审稿速度:2.0 | 投稿命中率:50.0
经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……

221 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2022-09-16 ms5000001050298954

我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊

123 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2023-03-21 Jacinth 来自广东省

想咨询一下这本杂志一般pending review几天？

116 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2023-11-08 ms6000000755861927 来自福建省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：11月1日投，11月8号大修

117 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254314, encodeId=4cb62254314c3, content=偏重的研究方向：肿瘤 经验分享：刚投，想问一下这个杂志对中国医院的文章友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Mon Mar 03 01:25:48 CST 2025, time=2025-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2248198, encodeId=95b4224819857, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Wed Jan 15 16:05:41 CST 2025, time=2025-01-15, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244852, encodeId=73a32244852ce, content=pend review 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJzQ3tL566pYyXic1eSIibaPodsLlh5zR5dUDJQqW8wIlY0Xic4QNrib14MmDFvwAnbibxkPWxjVtNY7w/132, createdBy=d1832010350, createdName=Jin0412, createdTime=Wed Dec 25 19:00:44 CST 2024, time=2024-12-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1227318, encodeId=0060122e31859, content=审稿速度:1.0 经验分享：从投稿到接受19天，非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Sun Jun 19 10:02:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215507, encodeId=9817221550ef8, content=要版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd835463069, createdName=ms8000001798355465, createdTime=Wed Jul 17 22:13:41 CST 2024, time=2024-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=955355, encodeId=1dba95535579, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3.5 投稿 3.10 under review 3.24 major revised 3.29 resubmited 4.7 minor revised 4.7 resubmited 4.8 accepted 审稿很有效率，审稿人也很耐心专业，问题很尖锐，知道哪里是痛点……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Fri Apr 09 00:42:05 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249357, encodeId=8746124935ee5, content=我想请问一下哈，under review是到审稿人那边了吗，还是说可能还在编辑手里啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9f88197404, createdName=ms5000001050298954, createdTime=Fri Sep 16 16:03:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120915, encodeId=3ba221209153f, content=想咨询一下这本杂志一般pending review几天？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Tue Mar 21 22:58:18 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167430, encodeId=8502216e43081, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：11月1日投，11月8号大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388d9023198, createdName=ms6000000755861927, createdTime=Wed Nov 08 16:52:00 CST 2023, time=2023-11-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1208392, encodeId=2e5f1208392a9, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：分子相关 经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/29/61916d37f00260943d1aefc338a64a59.jpg, createdBy=9ee81954970, createdName=柠檬cherry, createdTime=Sun Apr 03 17:35:10 CST 2022, time=2022-04-03, status=1, ipAttribution=)]

2022-04-03 柠檬cherry

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：分子相关
经验分享：投过，正文和sup的western需要原始扫描图片，投之前请准备好

153 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务